Results 121 to 130 of about 4,636,278 (309)

Adverse drug events affecting medication persistence with rivastigmine patch application

, 2018
Takashi Osada,1 Norio Watanabe,1 Naomitsu Asano,2 Yuzo Adachi,2 Keiko Yamamura1 1Clinical Pharmacy, School of Pharmacy, Aichi Gakuin University, Nagoya, Aichi, Japan; 2Sasayuri Pharmacy, Toki, Gifu, Japan Purpose: The rivastigmine transdermal patch ...
Osada T, Asano N, Yamamura K, Watanabe N, Adachi Y   +4 more
core  

White Matter Hyperintensity Burden and Short‐Interval Change Associated With Sleep Apnoea in the UK Biobank

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background and Purpose White matter hyperintensities (WMH) are a core neuroimaging marker of cerebral small vessel disease (CSVD). Sleep apnoea (SA) is a recognized vascular risk factor, but its associations with regional WMH burden, short‐interval WMH change and cognitive performance in population‐based cohorts remain incompletely defined. We
Peng Cheng, Diego Z. Carvalho, Shahid Karim, Anwar Chahal, Virend K. Somers   +4 more
wiley   +1 more source

PROFILE OF PATIENTS USING THE COFORMULATED DUAL REGIMEN LAMIVUDINE/DOLUTEGRAVIR FOLLOWED AT AN INFECTIOUS DISEASE REFERENCE HOSPITAL IN GOIÁS

Brazilian Journal of Infectious Diseases
Introduction: Advances in therapies, expanded access to treatment, and evolution of diagnostic methods have changed HIV infection from a lethal disease to a chronic illness controlled with adequate, continuous treatment. Considering the preferred regimen
Laíza Barbosa Guimarães, Maysa Aparecida de Oliveira   +1 more
doaj   +1 more source

Influenza Vaccination Responses in Disabled Stroke Patients: A Single‐Center Prospective Observational Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective This study aimed to investigate the immunological response to influenza vaccination, the incidence and severity of influenza infection, and the side effects of the vaccination in patients with ischemic stroke. Methods This prospective observational study was conducted between 2023 and 2024 at Ramathibodi Hospital.
Achiraya Pakngao, Sureerat Suwatcharangoon, Pintip Ngamjanyapron, Kobporn Boonnak, Thanitta Suangtamai, Porpon Rotjanapan   +5 more
wiley   +1 more source

Written reports of adverse events in acute care—A discourse analysis

, 2019
Adverse health care events are a global public health issue despite major efforts, and they have been acknowledged as a complex concern. The aim of this study was to explore the construction of unsafe care using accounts of adverse events concerning the ...
Wijk, Helle,, Ulin, Kerstin,, Helle Wijk, Gyberg, Anna, Margret Lepp, Anna Gyberg, Ingela Henoch, Henoch, Ingela,, Ulin, Kerstin, Kerstin Ulin, Gyberg, Anna,, Lepp, Margret, Lepp, Margret,, Wijk, Helle, Henoch, Ingela   +14 more
core   +1 more source

Safety and Tolerability of Givinostat: Evidence From Real‐World and Clinical Practice

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective The aim of our study was to establish the prevalence of adverse events in a real‐world setting in boys living with Duchenne muscular dystrophy (DMD) treated with givinostat as part of an Expanded Access Program (EAP) in Italy. Methods The cohort included 90 ambulant boys, with age when treatment started between 6 and 23 years (mean ...
Marika Pane, Anna Capasso, Chiara Arpaia, Adele D’Amico, Emilio Albamonte, Federica Trucco, Maria Sframeli, Riccardo Masson, Francesca Magri, Luca Bello, Romina Venditti, Claudia Dosi, Michela Catteruccia, Michele Tosi, Claudio Bruno, Sonia Messina, Giacomo Comi, Elena Pegoraro, Valeria A. Sansone, Eugenio Mercuri   +19 more
wiley   +1 more source

Dataset belonging to: Prediction of clinically relevant adverse drug events in surgical patients

, 2018
Contains the data used for the study titled: Prediction of clinically relevant adverse drug events in surgical patients. This dataset consists of data extracted from the P-REVIEW dataset.
Bos, dr. J.M. (Radboud University) DAI=info:eu-repo/dai/nl/310271134, Smet, prof. dr. P.A.G.M. de (Radboud University) DAI=info:eu-repo/dai/nl/071321144, Kramers, prof. dr. C. (Radboud University) DAI=info:eu-repo/dai/nl/142708208, Nagtegaal, J.E., Wieringa, A., van den Bemt, P.M., Groenewoud, drs. H. (Radboud University) DAI=info:eu-repo/dai/nl/298203332, Kalkman, Msc. G.A., van der Wilt, prof. dr. G.J. (Radboud University) DAI=info:eu-repo/dai/nl/101232691   +8 more
core   +1 more source

Evaluating adverse events in databases

Pharmacology Research & Perspectives, 2023
Katie Lovell, Steven R. Feldman
doaj   +1 more source

Risk of Non‐Arteritic Anterior Ischemic Optic Neuropathy in Idiopathic Intracranial Hypertension Patients Treated with GLP‐1 Receptor Agonists

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Introduction Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) have demonstrated significant weight‐reducing effects and may offer benefits in idiopathic intracranial hypertension (IIH); however, recent concerns about the risk of non‐arteritic anterior ischemic optic neuropathy (NAION) have emerged.
Faisal A. Al‐Harbi, Mohanad A. Alkuwaiti, Yazeed B. Alaql, Ahmed K. Alsaif, Ahmed A. Alessa, Meshari Ayed Alharbi, Mohammed Alfalah, Saud A. Alnaaim, Sajjad M. AlHaddad, Ahmed Y. Azzam   +9 more
wiley   +1 more source

Patient-reported health as a prognostic factor for adverse events following percutaneous coronary intervention

, 2014
Karin Biering,1 Hans Erik Bøtker,2 Troels Niemann,3 Niels Henrik Hjollund4,51Department of Occupational Medicine, Regional Hospital West Jutland, Herning, 2Department of Cardiology, Aarhus University Hospital, Skejby, Aarhus, 3Department of ...
Biering K, Hjollund NH, Niemann T, Bøtker HE   +3 more
core